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Abstract
Background: Rabies is traditionally considered a uniformly fatal disease after onset of clinical manifestations. However,
increasing evidence indicates that non-lethal infection as well as recovery from flaccid paralysis and encephalitis occurs in
laboratory animals as well as humans.
Methodology/Principal Findings: Non-lethal rabies infection in dogs experimentally infected with wild type dog rabies
virus (RABV, wt DRV-Mexico) correlates with the presence of high level of virus neutralizing antibodies (VNA) in the cerebral
spinal fluid (CSF) and mild immune cell accumulation in the central nervous system (CNS). By contrast, dogs that succumbed
to rabies showed only little or no VNA in the serum or in the CSF and severe inflammation in the CNS. Dogs vaccinated with
a rabies vaccine showed no clinical signs of rabies and survived challenge with a lethal dose of wild-type DRV. VNA was
detected in the serum, but not in the CSF of immunized dogs. Thus the presence of VNA is critical for inhibiting virus spread
within the CNS and eventually clearing the virus from the CNS.
Conclusions/Significance: Non-lethal infection with wt RABV correlates with the presence of VNA in the CNS. Therefore
production of VNA within the CNS or invasion of VNA from the periphery into the CNS via compromised blood-brain barrier
is important for clearing the virus infection from CNS, thereby preventing an otherwise lethal rabies virus infection.
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Introduction
Rabies is a highly lethal disease caused by the neurotropic rabies
virus (RABV). It has been estimated that about 55,000 persons died
from rabies each year mostly in Africa and Asia [1]. Successful
vaccines have been developed for the prophylaxis of the disease.
Timely post-exposure prophylaxis (PEP) can prevent the develop-
ment of rabies, when individuals are exposed to the virus. Unfortu-
nately, PEP is ineffective once clinical signs have appeared and virus
replicates in the CNS [2,3]. It is generally believed that virus clea-
rance is impossible once the virus reaches the brain [4,5]. However,
there is now increasing evidence that non-lethal infection can occur in
various animal species and in humans [6–8]. Up to date, six non-
lethal human rabies cases have been documented in the US alone [9–
13]. All these patients either had rabies specific antibodies in the
cerebral spinal fluids (CSF) at the time of hospitalization or after
treatment with the Milwaukee Protocol or a modification thereof
[14]. In addition, recovery of laboratory animals from clinical rabies
has also been reported [15]. It has been demonstrated in mice that the
clearance of the virus from the CNS requires the induction of innate
immune responses in the CNS, induction of RABV-specific adaptive
immunity in the periphery, as well as infiltration of immune effectors
across the blood-brain barriers (BBB) [16]. Roy et al. have demon-
strated that the lethality of infection with the silver-haired bat RABV
can be reduced by opening the BBB. Failure to enhance BBB
permeability prevents the delivery of immune effectors to the CNS
leading to the lethal outcome of rabies infection [17–19]. Although
chronic natural RABV infection in vampire bats [20], recovery from
experimental RABV infection in dogs and ferrets, and recovery of
humans from rabies has been documented [10,13,21], the mecha-
nism(s) involved in the prevention of lethal rabies are not completely
understood. These observations have led to renewed efforts to obtain
evidence of underlying mechanisms behind nonfatal rabies infections.
One of the major findings is that non-lethal wt RABV infection or
recovery from rabies correlates with the presence of VNA in the CSF
that presumably crossed the BBB [8,19,22].
In the present report, we describe the observation of non-lethal
infection in dogs after experimental infection with a wild type (WT)
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RABV that originated from a dog (DRV-Mexico) [23]. We found
that the non-lethal infection correlated with the presence of high
level VNA in the CSF, in contrast to lethal infection, where no or
only little VNA (,0.5 IU) were detected in the CSF. On the other
hand, vaccinated dogs resisted a challenge infection with no detec-
table VNA in the CSF but high VNA levels in the serum.
Methods
Viruses, animals, and reagents
Dog RABV (DRV-Mexico) was originally isolated from a dog of
Mexico origin [23,24]. Virus stocks were prepared by inoculating
10 ml of the virus by the intracerebral route into one-day-old
suckling mice. When moribund, the mice were euthanized and
brains removed. A 10% (w/v) suspension was prepared by homo-
genizing the brain in DMEM. The homogenate was centrifuged to
remove debris and the supernatant collected and stored at 280uC.
Healthy, non-rabies vaccinated, 5 month old clinically healthy
female beagles were obtained from Covance, USA. All the experi-
mental dogs were housed individually in temperature- and light-
controlled quarters in the Animal Facility, College of Veterinary
Medicine at University of Georgia. All animal experiments were
carried out under Institutional Animal Care and Use Committee-
approved protocols (animal welfare assurance number A3085-01).
Dog vaccination and infection
All the experimental dogs were pre-screened for the presence of
maternal VNA to RABV using the Rapid Fluorescent Focus
Inhibition Test (RFFIT). Dogs were sedated with Acepromazine,
an IM injection of phenothiazine derivative. Eight dogs were
randomly selected and infected intramuscularly (i.m) with 100 ml
viral suspension containing 200 MICLD50 (50% mouse intrace-
rebral lethal dose) of DRV-Mexico by direct inoculation into the
left hemisphere of the temporalis muscle. Another group of 4 dogs
were immunized with a RABV vaccine. The immunized dogs
were challenged after 4 weeks post immunization with 100 ml of
DRV suspension as described above. Dogs were observed at least
once a day prior to challenge and two to four times a day for 30
days after challenge. Humane endpoint of the study is the
appearance of hind limb paralysis of one or both limbs and the
experimental endpoint of the study was decided on the basis of
observed clinical signs for 30 days post challenge. Blood, CSF and
brain samples were collected before infection and/or at the time of
termination for various analyses including complete blood counts
(CBC), serum biochemistry, histopathology, immunohistochemistry,
antibody titration, and CSF cytology.
Histopathology and immunohistochemistry
For histopathology and immunohistochemistry, brain samples
were fixed in 10% neutral buffered formalin as described previ-
Author Summary
Inexorable lethality is still commonly attributed to rabies
infection, although there is increasing evidence for non-
lethal infection and even recovery from clinical rabies in
various animal species and humans. This paper reports non-
lethal infection in dogs. The striking difference between
dogs that survived a wt RABV infection and dogs that
succumbed to the infection is that the surviving dogs
showed high level of VNA in the serum and in the CSF, as
well as mild immune cell accumulation in the CNS, whereas
dogs that succumbed to disease showed little or no VNA in
the serum or in the CSF and developed severe CNS inflam-
mation. Considering the role of VNA in clearing the virus
from the CNS, production of VNA within the CNS or infiltra-
tion of VNA from the periphery into the CNS across the
blood-brain barrier appears to be important for clearing the
virus from CNS thereby preventing a lethal rabies infection.
Figure 1. Detection of VNA in the serum and CSF. CSF and serum samples were subjected to RFFIT for the analysis of virus neutralizing
antibodies (VNA). Statistical analysis was performed by student T test and the symbol *** indicates a p value ,0.0001, ** indicates a p value ,0.001
and * indicates a p value ,0.05.
doi:10.1371/journal.pntd.0002375.g001
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ously [25]. Brains were removed and paraffin embedded for
coronal sections. For de-paraffinization, slides were heated at 60uC
for 25 min and then dipped in CitriSolv (Fisher Scientific, PA)
three times for 5 min and dried until chalky white. The slides were
then stained with hematoxylin and eosin (H&E). Slides were
heated in antigen unmasking solution (Vector Laboratories, CA)
above 90uC for 20 min and allowed to cool down to room
temperature. Anti-RABV N monoclonal antibody Mab N42 and
Anti-RABV G Mab 53 were used to detect the viral antigens N
and G, respectively [26]. Biotinylated secondary antibodies were
used for detection as described [27], with avidin–biotin–peroxidase
complex (Vector Laboratories, CA) and diaminobenzidine (DAB) as
a substrate for color development. The intensity of DAB signals
corresponding to CD3 antigen was quantified manually to obtain
statistical analysis. Both the histopathology and immunohistochem-
istry slides were read and interpreted by the same pathologist.
Clinical pathology
The blood and CSF samples were collected before and after
infection and sent to the Clinical Pathology Laboratory at
University of Georgia for analysis. Blood samples were collected
in plastic tubes coated with or without EDTA anticoagulant from
the jugular vein or cephalic veins. Whole blood and serum were
analyzed for hematology parameters and chemistry parameters,
Table 1. Summary of immune responses in dogs.
Dog ID CSF-WBC/ml CSF-Total Protein-mg/dl Serum VNA –IU CSF VNA –IU Status
Pre End of study Pre End of study Pre
Immunized before
challenge
End of
study Pre
End of
study
CEM 5 256 13.6 72.8 0.03 - 0.85 0 0.29 Dead
CLJ 0 363 10.1 66 0.07 - 0.35 0 0.02 Dead
CIJ 2 408 12.6 54.4 0.07 - 0.05 0 0.01 Dead
CFA 2 23 11.8 26.8 0.1 - 9.85 0 7.79 Recovered
CFB 0 33 12.2 32 0.2 - 7.5 0 2.6 Recovered
CGW 2 39 13.7 42 0.06 - 7.5 0 7.79 Recovered
CGT 1 21 13.9 19.7 0.09 - 3.3 0 1.5 Recovered
CGU 3 29 13.9 27 0.06 - 4.35 0 5.92 Recovered
CEH ND 6 ND 14.5 0.01 9.85 1.7 ND 0 vaccinated
CEN ND 8 ND 13.4 0.01 29.6 1.7 ND 0 vaccinated
CEZ ND 8 ND 13.7 0.01 29.6 2.9 ND 0 vaccinated
CII ND 0 ND 13.1 0.02 17.1 0.7 ND 0 vaccinated
Summary of total protein, virus neutralizing antibodies and/or WBC counts in the CSF and serum, of rabid, recovered and vaccinated dogs. ND: Not done.
doi:10.1371/journal.pntd.0002375.t001
Figure 2. Measurement of WBC and total protein in the CSF. CSF samples obtained from DRV Mexico infected dogs were subjected to clinical
pathological analysis. Statistical analysis was performed by student T test and the symbol *** indicates a p value ,0.0001, ** indicates a p value
,0.001 and * indicates a p value ,0.05.
doi:10.1371/journal.pntd.0002375.g002
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respectively. CBCs were performed on Siemens Bayer Advia 120
using flow cytometry laser light scatter methodology. Serum
chemistry is performed on Roche Hitachi P Module analyzer. The
CSF samples were collected from the cerebellomedullary cistern
site and were evaluated for various inflammatory parameters, such
as, white blood cell counts (WBC) and total protein concentration.
CSF cytology is performed by counting the cells on a Neubauer
Hemocytometer and a cytospin smear is made to differentiate the
cells counted. The resulting smear is stained on the Wescor stainer
and evaluated microscopically. In addition, the color and trans-
parency is recorded by visual inspection by the technologists. The
CSF protein is measured on the Roche Hitachi P module.
RFFIT
Blood and CSF samples were collected for measurement of
VNA using the RFFIT (Rapid Fluorescent Focus Inhibition Test)
as described previously [20]. Briefly, 50 ml of serial five-fold
dilutions of serum were prepared in Lab-Tek Chamber slides
(Nalge Nunc International, Rochester, NY). Fifty FFD50 (50%
Fluorescing Foci dose) of CVS-11 was added to each chamber and
incubated for 90 min at 37uC. NA cells (105 cells) were added into
each chamber and the slides were incubated at 37uC for 20 hr,
fixed with ice-cold 80% acetone and stained with FITC-conjugated
anti-RABV N antibodies for 1 hr at 37uC. Twenty fields in each
chamber were observed under a fluorescent microscope, and the
50% endpoint titers were calculated according to the Reed-Muench
formula. The values were compared with that of reference serum
(obtained from the National Institute for Biological Standards and
Control, Herts, UK) and normalized to international units (IU/ml).
Ethics statement
The project AUP is entitled, ‘‘Virus clearance from the central
nervous system’’ and the AUP number is A2011 03-016. It was
approved by the University of Georgia’s Institutional Animal Care
and Use Committee on 4 APR 2011, and will expire on 4 APR
2014. The University of Georgia’s University Research Animal
Resources unit is fully accredited by the Association for Assess-
ment and Accreditation of Laboratory Animal Care, International
(AAALAC-I). The registration number from the U.S. Department
of Agriculture, Animal and Plant Health Inspection Service,
Animal Care is (USDA APHIS-AC). We have an assurance on file
with the NIH-Office of Laboratory Animal Welfare (NIH-OLAW),
and are in compliance with the PHS Policy on Humane Care and
Use of Laboratory Animals and the 8th edition of the Guide for the
Care and Use of Laboratory Animals, 2011.
Statistical analysis
Statistical significance of the differences between groups was tested
using student’s T test with *** indicating a p value ,0.0001, ** a p
value,0.001, and * a p value,0.05 using GraphPad prism software.
Results
Clinical observations of dogs after infection with DRV-
Mexico
Among the eight dogs infected with DRV-Mexico, three dogs
showed typical signs of the dumb or paralytic form of rabies at 11,
12, and 21 days post infection (dpi), respectively. Early signs
consisted of subtle changes in behavior, including quietness, hiding
in the corner of the cage, lethargy and loss of appetite. Later signs
included agitation, poor coordination, tremors, trembling, persis-
tent regurgitation and retching, excess salivation and paralysis.
Among these dogs, only one showed signs of furious form of rabies
such as aggressiveness, whining and barking. The rabid dogs
reached the end point of the study (hind limb paralysis) and were
sacrificed on 13, 14, and 22 dpi, respectively. The other 5 infected
dogs exhibited only the subtle behavior changes, which began on
13 dpi, and appeared normal again by 21 dpi. At 30 dpi, all
surviving dogs were sedated and after blood and CSF collection
were euthanized and their brains removed for analysis. None of
the dogs in the vaccinated group (n-4) showed any clinical signs
indicative of rabies infection during the 30 day observation period
after which they were euthanized.
VNA responses in the serum and the CSF in the dogs
All the serum and CSF samples were subjected to RFFIT
analysis for VNA. None of the dogs had detectable VNA in either
the serum or the CSF prior to infection or vaccination. Serum and
CSF VNA titers detected in terminally ill dogs at the time of
euthanization were only 0.4260.41 and 0.160.15 IU/ml, respec-
tively. VNA titers determined in the serum and CSF of the
surviving dogs were 6.562.6 and 5.162.9 IU, respectively, at
30 dpi (Fig. 1 & table 1). The vaccinated group had serum VNA
titers of 21.569.7 IU prior to challenge with 1.7560.9 IU in
serum and no detectable VNA in CSF at 30 dpi (Fig. 1 & table 1).
The high VNA levels in the serum of the dogs recovering from
clinical signs of rabies indicates that they were infected with the
virus and the presence of VNA in CSF strongly suggests that the
virus invaded their CNS, and VNA contributed to their survival.
Dogs that developed lethal rabies did not develop detectable VNA
levels in CSF.
Total protein level and WBC counts in the CSF of dogs
Total protein and WBC counts in the CSF were also analyzed.
As shown in Fig. 2, no WBC were detected in the CSF and total
protein was 12.761.3 mg/dl in dogs prior to infection or in the
immunized dogs, indicating that the BBB remained intact in these
animals. Total proteins (64.469.3 mg/dl) andWBC counts (342.36
78.1 cells/ml) increased dramatically in the CSF of terminally ill
dogs, indicating a strong CNS inflammatory response (Fig. 2 &
table 1). In the surviving dogs, total proteins (29.568.2 mg/dl) and
WBC counts (29.067.3 cells/ml) in CSF were higher than those in
the dogs prior to infection or in the immunized animals, but were
much lower than those in the terminally ill animals. The relatively
large amount of WBC and proteins in CSF suggest that BBB
permeability is enhanced in DRV-Mexico-infected dogs.
Pathology and infiltration of inflammatory cells in the
CNS of dogs
To determine whether the apparent changes in BBB perme-
ability were reflected in the infiltration of immune/inflammatory
cells into the brain, brains were collected from the immunized,
surviving and terminally ill animals for histopathology and
immunohistochemistry. Increased cell infiltrates and perivascular
Figure 3. Infiltration of inflammatory cells into the CNS of dogs. Paraffin sections obtained from DRV Mexico infected dog brains were
subjected to HE staining (A) or immunohistochemistry for detecting CD3-positive cells (B). Three serial sections and two vessels were selected from
each dog for quantification, and the average numbers of CD3-positive cells, degenerated neurons and perivascular infiltrated cells obtained were
used for statistical analysis (C). Statistical analysis was performed by student T test and the symbol *** indicates a p value ,0.0001, ** indicates a p
value ,0.001 and * indicates a p value ,0.05.
doi:10.1371/journal.pntd.0002375.g003
Non-Lethal Rabies Infection in Dogs
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cuffing of mononuclear cells with marked activation of microglial
cells were found in the hippocampus, hypothalamus and
cerebellum of dogs that succumbed to rabies. Only residual cell
accumulation was observed in the recovered dogs while evidence
of inflammation was absent in the immunized dogs (Fig. 3A). To
quantify immune cell infiltration into the CNS, CD3-bearing cells
were assessed in various brain regions by immunohistochemistry.
As shown in Fig. 3B, more CD3-positive cells were found in the
hippocampus and hypothalamus of dogs that succumbed to rabies
than in the same regions of recovered dogs. CD3 positive cells
were not observed in the CNS tissues of immunized dogs (Fig. 3B).
Quantification of CD3-positive cells in different parts of the brains
of the groups of animals indicates that there were indeed signifi-
cantly more CD3+ cells in the CNS of the dogs that succumbed to
rabies than in those that survived (Fig. 3C).
Viral antigens in the CNS of dogs
In order to correlate the development of rabies with virus loads
in the CNS, brain tissues were evaluated for viral G and N antigens
by immunohistochemistry. As shown in Fig. 4, viral antigens were
detected only the hippocampus, hypothalamus and cerebellum of
the dogs that succumbed to rabies. Relatively high numbers of cells
positive for rabies G (Fig. 4A) and N (Fig. 4B) were detected in the
hippocampus and hypothalamus, whereas such were only sparsely
detected in the cerebellum. No viral antigens were detected in the
CNS of recovered or immunized dogs.
Discussion
Despite the extensive progress in rabies research since the time
of Pasteur, more than 55,000 people continue to die of rabies each
year world-wide [28]. Once symptoms occur, rabies is almost
always fatal. Recently, however, cases of non-lethal rabies infection
and recovery from clinical rabies in laboratory animals and humans
have been reported [6,10,21,29–32]. One of the major findings
associated with these non-lethal infections is that many of the
survivors had VNA in the CSF [6,10,22,29,32,33]. Consistent with
these findings, we report in the present paper that experimental
infection of dogs with a wt RABV is not invariably lethal, and that
survival correlates with the presence of high VNA titers, evidence of
WBC infiltration, and elevated levels of protein in the CSF.
PEP is effective in preventing rabies after exposure providing that
clinical signs of rabies have not appeared. Consisting of vaccination
with RABV vaccines and administration of anti-rabies immuno-
globulin at the site of exposure and systemically [34], it is believed
that PEP prevents the rabies virus from invading the CNS due to the
long incubation period of the infection [35]. It has long been
thought that it is difficult to clear the virus once it enters into the
CNS [4,36]. This dogma was initially cast into doubt by the finding
that RABV can be cleared form the CNS by VNA administered
intravenously [37]. Recently it has been found that enhancement of
the BBB permeability prevents rabies in the mouse model by allow-
ing immune effectors from the periphery to enter into and clear
RABV from the CNS [16]. Various studies have been conducted
using different models to promote immune cell infiltration into the
CNS in rabies including experimental allergy encephalitis, in which
the disease enhances BBB permeability [38], and infection with
attenuated RABV such as recombinant viruses that express three
copies of G [39] or immune stimulating agents [40].All of these
interventions result in an immune response to RABV in the CNS
and reduce fatalities in mice infected with wt RABV [17–19].
However, simply targeting BBB integrity alone is not sufficient
to protect mice from lethal rabies since administration of a chemo-
kine, MCP-1, enhanced BBB permeability but did not significantly
increase the survival rate of mice infected with DRV-Mexico [41].
Neither does immunization with an inactivated RABV prepara-
tion 5 days after infection with DRV-Mexico despite inducing
serum VNA. On the other hand, administration of MCP-1 to mice
immunized with inactivated RABV significantly improved their
survival from DRV-Mexico indicating that the combined effects of
enhancement of BBB permeability and the production of rabies-
specific VNA is protective [41]. In the present study, none of the
dogs that succumbed to rabies had serum VNA=/.0.5 IU and
their CSF VNA were even lower (,0.1 IU). This is despite the
possibility that BBB permeability became enhanced at the end of
their lives as suggested by the greater numbers of WBC and high
protein levels detected in their CSF. In the dogs with non-lethal
infection, BBB permeability had likely been enhanced at some
stage since VNA, WBC, and high protein levels were detected in
their CSF. Moreover, residual CD3 cell accumulation was observed
but no virus antigen in the CNS tissues of these dogs at the time of
sacrifice, suggesting that immune effectors acting in the CNS had
cleared the virus. In the mouse model, lethal infection with wt
RABV (DRV-Mexico) is not accompanied by enhanced BBB
permeability (cerebrum, cerebellum, or spinal cord) at days 6 or
9 dpi when RABV antigens or RNA are detected in the CNS [19].
This is consistent with observations in mice of lethal infections with
a variety of other wild-type RABV [42]. The apparent discrepancies
observed betweenmice and dogs in the loss of BBB integrity indicate
that the pathogenic processes in these two animal species may be
somewhat different. Also, these discrepancies in BBB permeability
may be due to the close co-adaptation of viral strain to their specific
homologous host (dogs) than the spillover. Nevertheless, the correla-
tion between the presence of VNA in the CSF and the clearance of
RABV from the CNS is shared. In 3 of the humans that recovered
from rabies, whether treated with the Milwaukee protocol or not,
virus specific antibodies were detected in their CSF at the time of
hospitalization [10,29,43]. In dogs recovered from infection with
laboratory-attenuated virus, VNA was also detected in the CSF
[44]. A ferret that recovered from rabies encephalitis also had
detectable VNA in the CSF [32]. In our study, the dogs surviving wt
RABV infection developed only mild disease without typical rabies
symptoms yet developed high VNA levels in both serum and CSF.
Particularly, the presence of VNA in CSF strongly suggests that the
virus invaded their CNS. This is very different from immunized
dogs in which VNA was produced in the serum, but not in the CSF.
The detection of VNA in CSF and evidence of limited immune cell
infiltration into CNS tissues makes it likely that the dogs survived the
wt RABV infection by clearing the virus from the CNS. Thus we
conclude that, like humans and other species [8,9–14,43], infection
of dogs with wt RABV is not invariably lethal even when the virus
has reached the CNS. The mechanisms whereby certain dogs
mediated an RABV-specific immune response that reached in the
CNS and survived while others did not remain to be understood and
may provide the foundations for the development of novel
therapeutic intervention strategies for clinical rabies.
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